2.1801
6.07%
0.1201
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TPST?
Forum
Prognose
Aktiensplit
Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten
Ready to Jump After Recent Trade: Tempest Therapeutics Inc (TPST) – Sete News - SETE News
SETE News
Ratios in Focus: Analyzing Tempest Therapeutics Inc (TPST)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
The Dwinnex
Ratios in Focus: Analyzing Tempest Therapeutics Inc (TPST)'s Price-to-Cash and Price-to-Free Cash Flow – DWinneX - The Dwinnex
The Dwinnex
A stock that deserves closer examination: Tempest Therapeutics Inc (TPST) – US Post News - US Post News
US Post News
William Blair Equities Analysts Decrease Earnings Estimates for Tempest Therapeutics, Inc. (NASDAQ:TPST) - Defense World
Defense World
Tempest Therapeutics (NASDAQ:TPST) Given Overweight Rating at Piper Sandler - Defense World
Defense World
Market cap of Tempest Therapeutics Inc [TPST] reaches 44.66M – now what? – The DBT News - The DBT News
The DBT News
Tempest Therapeutics (NASDAQ:TPST) Given Buy Rating at HC Wainwright - Defense World
Defense World
In the Green: Tempest Therapeutics Inc (TPST) Closes at 2.01, Up/Down -29.47 from Previous Day – DWinneX - The Dwinnex
The Dwinnex
Tempest Therapeutics (NASDAQ:TPST) Given Buy Rating at HC Wainwright - Defense World
Defense World
The TPST Stock Puzzle: Unraveling Tempest Therapeutics Inc’s Fluctuating Performance - The InvestChronicle
The InvestChronicle
Tempest stock falls after trial data for liver cancer drug (NASDAQ:TPST) - Seeking Alpha
Seeking Alpha
Tempest Flounders on News of Test Results - Baystreet.ca
Baystreet.ca
What's Going On With Cancer-Focused Tempest Therapeutics Stock On Thursday? - Tempest Therapeutics (NASDAQ ... - Benzinga
Benzinga
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a ... - GlobeNewswire
GlobeNewswire
Why Is Tempest Therapeutics (TPST) Stock Up 45% Today? - InvestorPlace
InvestorPlace
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a ... - StockTitan
StockTitan
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace
InvestorPlace
Tempest Therapeutics Inc (TPST) stock analysis: A simple moving average approach – US Post News - US Post News
US Post News
Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line ... - GlobeNewswire
GlobeNewswire
Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line ... - StockTitan
StockTitan
Take off with Tempest Therapeutics Inc (TPST): Get ready for trading – Sete News - SETE News
SETE News
Tempest Therapeutics Inc Inc. (TPST) Price Performance: The Role of Supply and Demand - The InvestChronicle
The InvestChronicle
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Yahoo Finance
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Yahoo Finance
Tempest Therapeutics (NASDAQ:TPST) Stock Price Down 2.1% - MarketBeat
MarketBeat
Tempest Therapeutics (NASDAQ:TPST) Trading Down 2.1% - MarketBeat
MarketBeat
Tempest Therapeutics (NASDAQ:TPST) Stock Price Down 2.1% - MarketBeat
MarketBeat
Tempest Therapeutics (NASDAQ:TPST) Trading Down 2.1% - Defense World
Defense World
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST) - Business Wire
Business Wire
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST) - Business Wire
Business Wire
Get in on Tempest Therapeutics Inc's (TPST) buy-in window today! – Sete News - SETE News
SETE News
Tempest to Participate in Upcoming Investor Conferences - Yahoo Finance
Yahoo Finance
Tempest to Participate in Upcoming Investor Conferences - Yahoo Finance
Yahoo Finance
Short Interest in Tempest Therapeutics, Inc. (NASDAQ:TPST) Increases By 39.8% - MarketBeat
MarketBeat
Short Interest in Tempest Therapeutics, Inc. (NASDAQ:TPST) Increases By 39.8% - MarketBeat
MarketBeat
Tempest Therapeutics' (TPST) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
MarketBeat
Tempest Therapeutics' (TPST) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
MarketBeat
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance
Yahoo Finance
Tempest Therapeutics (NASDAQ:TPST) Stock Price Up 1.1% - Defense World
Defense World
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
GlobeNewswire
The Tempest Therapeutics Inc (TPST) had a good session last reading, didn't it? – US Post News - US Post News
US Post News
Tempest Therapeutics: Multiple 2024 Catalysts Make This A Must Watch (NASDAQ:TPST) - Seeking Alpha
Seeking Alpha
Bears are Losing Control Over Tempest Therapeutics, Inc. (TPST), Here's Why It's a 'Buy' Now - Yahoo Movies UK
Yahoo Movies UK
Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting - GlobeNewswire
GlobeNewswire
Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting - Yahoo Finance
Yahoo Finance
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Kapitalisierung:
|
Volumen (24h):